Literature DB >> 32789467

Travel-related hepatitis E: a two-decade GeoSentinel analysis.

Laura Ambra P Nicolini1, Rhett J Stoney2, Andrea Della Vecchia3,4, Martin Grobusch5, Philippe Gautret6, Kristina M Angelo2, Perry J J van Genderen7, Emmanuel Bottieau8, Karin Leder9, Hilmir Asgeirsson10, Daniel T Leung11, Bradley Connor12, Prativa Pandey13, Federica Toscanini1, Federico Gobbi14, Francesco Castelli15, Matteo Bassetti1,3, Davidson H Hamer16,17,18.   

Abstract

BACKGROUND: Hepatitis E virus (HEV) is widely distributed worldwide and is endemic in developing countries. Travel-related HEV infection has been reported at national levels, but global data are missing. Moreover, the global availability of HEV diagnostic testing has not been explored so far. The aim of this study is to describe the epidemiology of HEV infections in returning travellers and availability of HEV diagnostic testing in the GeoSentinel surveillance network.
METHODS: This was a multicentre retrospective cross-sectional study. All confirmed and probable HEV travel-related infections reported in the GeoSentinel Network between 1999 and 2018 were evaluated. GeoSentinel sites were asked to complete a survey in 2018 to assess the availability and accessibility of HEV diagnostic procedures (i.e. serology and molecular tests) throughout the study period.
RESULTS: Overall, 165 travel-related HEV infections were reported, mainly since 2010 (60%) and in tourists (50%). Travellers were exposed to hepatitis E in 27 countries; most travellers (62%) were exposed to HEV in South Asia. One patient was pregnant at the time of HEV infection and 14 had a concomitant gastrointestinal infection. No deaths were reported. In the 51% of patients with information available, there was no pre-travel consultation. Among 44 GeoSentinel sites that responded to the survey, 73% have access to HEV serology at a local level, while 55% could perform (at a local or central level) molecular diagnostics.
CONCLUSION: Reported access to HEV diagnostic testing is suboptimal among sites that responded to the survey; this could negatively affect diagnosing HEV. Pre-travel consultations before travel to South Asia and other low-income and high-prevalence areas with a focus on food and water precautions could be helpful in preventing hepatitis E infection. Improved HEV diagnostic capacity should be implemented to prevent and correctly diagnose travel-related HEV infection. © International Society of Travel Medicine 2020. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HEV; epidemiology; geosentinel; hepatitis; travel

Mesh:

Year:  2020        PMID: 32789467      PMCID: PMC9494553          DOI: 10.1093/jtm/taaa132

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   39.194


  25 in total

1.  Hepatitis E virus infections in Europe.

Authors:  Jacques Izopet; Pauline Tremeaux; Olivier Marion; Marion Migueres; Nicolas Capelli; Sabine Chapuy-Regaud; Jean-Michel Mansuy; Florence Abravanel; Nassim Kamar; Sébastien Lhomme
Journal:  J Clin Virol       Date:  2019-09-08       Impact factor: 3.168

2.  EASL Clinical Practice Guidelines on hepatitis E virus infection.

Authors: 
Journal:  J Hepatol       Date:  2018-03-31       Impact factor: 25.083

3.  The incidence of hepatitis E virus infection in the general population of the USA.

Authors:  M F Faramawi; E Johnson; S Chen; P R Pannala
Journal:  Epidemiol Infect       Date:  2010-09-21       Impact factor: 2.451

4.  Fulminant hepatic failure from hepatitis E in a non-pregnant female traveller.

Authors:  Robert B Chris; Jay S Keystone
Journal:  J Travel Med       Date:  2016-04-11       Impact factor: 8.490

5.  Surveillance for travel-related disease--GeoSentinel Surveillance System, United States, 1997-2011.

Authors:  Kira Harvey; Douglas H Esposito; Pauline Han; Phyllis Kozarsky; David O Freedman; D Adam Plier; Mark J Sotir
Journal:  MMWR Surveill Summ       Date:  2013-07-19

Review 6.  Hepatitis E virus infection.

Authors:  Nassim Kamar; Jacques Izopet; Nicole Pavio; Rakesh Aggarwal; Alain Labrique; Heiner Wedemeyer; Harry R Dalton
Journal:  Nat Rev Dis Primers       Date:  2017-11-16       Impact factor: 52.329

7.  Factors Affecting Pre-Travel Health Seeking Behaviour and Adherence to Pre-Travel Health Advice: A Systematic Review.

Authors:  Dylan Kain; Aidan Findlater; David Lightfoot; Timea Maxim; Moritz U G Kraemer; Oliver J Brady; Alexander Watts; Kamran Khan; Isaac I Bogoch
Journal:  J Travel Med       Date:  2019-09-02       Impact factor: 8.490

8.  Genotype-Specific Evolution of Hepatitis E Virus.

Authors:  Adam B Brayne; Bethany L Dearlove; James S Lester; Sergei L Kosakovsky Pond; Simon D W Frost
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

9.  Hepatitis E should be considered a neglected tropical disease.

Authors:  Andrew S Azman; Iza Ciglenecki; Joseph F Wamala; Julia Lynch; Rakesh Aggarwal; Mahmudur Rahman; Sid Wong; Micaela Serafini; Ali M Moussa; Harry R Dalton; Ananta Shrestha; Rajendra Pant; Raquel Peck; Emily S Gurley
Journal:  PLoS Negl Trop Dis       Date:  2019-07-25

10.  Hepatitis E in Long-Term Travelers from the Netherlands to Subtropical and Tropical Countries, 2008-2011.

Authors:  Floortje Elfrink; Femke W Overbosch; Janke Schinkel; Gerrit Koen; Gerard J B Sonder
Journal:  Emerg Infect Dis       Date:  2018-06       Impact factor: 6.883

View more
  1 in total

Review 1.  GeoSentinel: past, present and future†.

Authors:  Davidson H Hamer; Aisha Rizwan; David O Freedman; Phyllis Kozarsky; Michael Libman
Journal:  J Travel Med       Date:  2020-12-23       Impact factor: 8.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.